Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Reinforced anti-adhesion composite gel, preparation method and application

A composite gel and anti-adhesion technology, applied in medical science, surgery, etc., can solve the problems of unsatisfactory effect, difficulty in ensuring the concentration and time of wound site, etc., to enhance the mechanical isolation effect, prevent platelet aggregation and activation, and speed up repair. healing effect

Active Publication Date: 2013-05-29
SUZHOU BOCHUANG TONGKANG PHARM TECH CO LTD
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

As a mechanical barrier, it covers tissue or organ wounds in the form of gel or film. It has the characteristics of good absorption and good biocompatibility, but it is absorbed and degraded in about 4 days in the body. However, the completion of adhesion after injury requires For more than 7 days, carboxymethyl cellulose, carboxymethyl chitosan, and hyaluronic acid alone are not effective in preventing adhesions
[0007] In recent years, carboxymethyl cellulose, carboxymethyl chitosan, and hyaluronic acid sugar have been used clinically to prevent adhesions. They are solutions or gels, but they will flow with the body position after being placed in the body. Ensure its concentration and time at the wound site

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0024] Weigh 2.5 grams of medicinal-grade sodium carboxymethyl cellulose, add 80 ml of water for injection, heated water bath (30~60℃) and stir to dissolve; add 50 mg of functional peptide, the amino acid sequence is: lysine-lysine- Threonine-serine-arginine-glycine-aspartic acid-serine, mix well; add 1.5g of chitosan (molecular weight 10000~20,000), stir while adding, then add water for injection to 100ml, stir well Until a homogeneous gel without flocculation is formed, the sterilization treatment is performed to obtain a strengthened anti-adhesion composite gel.

Embodiment 2

[0026] Weigh 2 grams of medicinal-grade carboxymethyl chitosan, first add 80 ml of water for injection heating water bath (30 ~ 60 ℃) and stir to dissolve; add 60 micrograms of functional peptide, the amino acid sequence is: lysine-lysine- Cysteine-serine-arginine-glycine-aspartic acid-serine-cysteine-lysine-lysine (condensable into cyclic), stir well; add 2.0 g chitosan ( (Molecular weight 2000-3000), stir while adding, then add water for injection to 100 ml and stir evenly to form a uniform gel without flocculation, and sterilize to obtain a strengthened anti-adhesion composite gel.

Embodiment 3

[0028] Weigh 1.5 g of medicinal-grade hyaluronic acid, add 80 ml of water for injection, heated water bath (30~60℃) and stir to dissolve; add 100 micrograms of functional peptide, the amino acid sequence is: lysine-lysine-threonine -Serine-Arginine-Glycine-Aspartic acid-Serine, stir well; add 0.05 g of polylysine (molecular weight 3000-5000), stir while adding, then add water for injection to 100 ml and stir evenly to form Non-flocculent uniform gel, sterilized treatment to strengthen anti-adhesion composite gel.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the field of biological medicinal materials, and discloses a reinforced anti-adhesion composite gel. The reinforced anti-adhesion composite gel comprises the following components in mass / volume ratio: 0.01 to 8 percent of polysaccharide with anionic groups, 0.0000001 to 1 percent of functional polypeptide with positive charge groups, and 0.05 to 5 percent of polysaccharide with cationic groups or cationic polymerized polypeptide or mixture of the two in any ratio. The invention also provides a preparation method for the reinforced anti-adhesion composite gel. The reinforced anti-adhesion composite gel can effectively reduce the occurrence of adhesion by adding the anti-adhesion functional polypeptide with polyelectrolyte interaction and the polysaccharide with cationic groups and / or cationic polymerized polypeptide into materials.

Description

Technical field [0001] The invention belongs to the field of biomedical materials, and relates to a composite gel with enhanced anti-adhesion function after surgical operation, and a preparation method and application thereof. Background technique [0002] Adhesion between tissues and organs after surgery is a common clinical disease. Adhesion is an abnormal structure formed by the combination of connective tissue fiber bands with adjacent tissues or organs. The formation of adhesions is universal, and it is reported that 50% to 100% of abdominal and pelvic surgery can lead to different degrees of adhesions. Serious clinical complications caused by adhesions include intestinal obstruction, infertility, chronic pelvic pain, etc., which increase the difficulty of reoperation and the potential for further complications. Therefore, in-depth exploration of the causes of adhesion formation and prevention and reduction of postoperative adhesions has become a key research and applicatio...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61L31/12A61L31/04C08J3/075C08L5/08C08L5/06C08L1/08
Inventor 吴昌琳
Owner SUZHOU BOCHUANG TONGKANG PHARM TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products